Jonathan Lewis

2009

In 2009, Jonathan Lewis earned a total compensation of $2.1M as Chief Executive Officer at ZIOPHARM Oncology.

Compensation breakdown

Bonus$200,000
Option Awards$384,500
Salary$420,000
Stock Awards$1,045,500
Other$77,343
Total$2,127,343

Lewis received $1M in stock awards, accounting for 49% of the total pay in 2009.

Lewis also received $200K in bonus, $384.5K in option awards, $420K in salary and $77.3K in other compensation.

Rankings

In 2009, Jonathan Lewis' compensation ranked 2,236th out of 9,885 executives tracked by ExecPay. In other words, Lewis earned more than 77.4% of executives.

ClassificationRankingPercentile
All
2,236
out of 9,885
77th
Division
Manufacturing
785
out of 3,690
79th
Major group
Chemicals And Allied Products
152
out of 871
83rd
Industry group
Drugs
88
out of 643
86th
Industry
Pharmaceutical Preparations
69
out of 446
85th
Source: SEC filing on April 30, 2012.

Lewis' colleagues

We found one more compensation record of an executive who worked with Jonathan Lewis at ZIOPHARM Oncology in 2009.

2009

Richard Bagley

ZIOPHARM Oncology

Chief Financial Officer

You may also like